Cara Therapeutics, Inc. (CARA)
15.96
-0.69 (-4.14%)
Inactive · Last trade price on Apr 15, 2025

Cara Therapeutics Stock Forecast

Stock Price Forecast

The 3 analysts with 12-month price forecasts for Cara Therapeutics stock have an average target of 12, which predicts a -24.81% decrease from the current stock price of 15.96.

Price Target: $12 (-24.81%)
Analyst Consensus: Hold
TargetLowAverageMedianHigh
Price$12$12$12$12
Change-24.81%-24.81%-24.81%-24.81%
* Price targets were last updated on Jun 13, 2024.

Analyst Ratings

The average analyst rating for Cara Therapeutics stock from 3 stock analysts was "Hold". This means that analysts believed this stock was likely to perform similarly to the overall market.

Recommendation Trends

RatingNov '24Dec '24Jan '25Feb '25Mar '25Apr '25
Strong Buy222220
Buy000000
Hold444443
Sell000000
Strong Sell000000
Total666663

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Canaccord Genuity
Canaccord Genuity
Hold
Downgrades
$120$12
HoldDowngrades$120$12-24.81%Jun 13, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Hold
Downgrades
n/a
HoldDowngradesn/an/aJun 13, 2024
Needham
Needham
Hold
Downgrades
n/a
HoldDowngradesn/an/aJun 13, 2024
Needham
Needham
Strong Buy
Reiterates
$60
Strong BuyReiterates$60+275.94%May 23, 2024
HC Wainwright & Co.
HC Wainwright & Co.
Strong Buy
Reiterates
$43
Strong BuyReiterates$43+170.68%May 15, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
3.67M
from 7.14M
Decreased by -48.55%
Revenue Next Year
1.53M
from 3.67M
Decreased by -58.33%
EPS This Year
-0.79
from -15.53
EPS Next Year
-0.65
from -0.79
Fiscal YearFY 2020FY 2021FY 2022FY 2023FY 2024FY 2025FY 2026FY 2027
Period EndingDec 31, 2020Dec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026Dec 31, 2027
Revenue
135.08M23.03M41.87M20.97M7.14M3.67M1.53M19.33M
Revenue Growth
579.28%-82.95%81.81%-49.92%-65.96%-48.55%-58.33%1,163.20%
EPS
2.13-20.93-19.12-26.26-15.53-0.79-0.65-0.73
EPS Growth
--------
Forward PE
--------
No. Analysts
-----554
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue202520262027
High3.8M1.6M26.5M
Avg3.7M1.5M19.3M
Low3.5M1.5M12.4M

Revenue Growth

Revenue Growth202520262027
High
-47.0%
-57.1%
1,629.2%
Avg
-48.5%
-58.3%
1,163.2%
Low
-50.6%
-60.0%
713.5%

EPS Forecast

EPS202520262027
High-0.36-0.34-0.33
Avg-0.79-0.65-0.73
Low-1.11-1.10-1.10

EPS Growth

EPS Growth202520262027
High---
Avg---
Low---
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.